Besides, several lines of evidence suggested that TJP2 expression is silenced in multiple carcinomas, including breast carcinoma [32], pancreas adenocarcinoma [33] and as well as in a hypoxia-resistant cancer cell lines derived from a scirrhous gastric carcinoma [34]. This evidence concerns the gene TJP2 and breast carcinoma.